Não é conhecido antídoto específico para este produto. Em caso de superdose recomendam-se as medidas de suporte clínico e tratamento sintomático.
Em caso de intoxicação ligue para 0800 722 6001, se você precisar de mais orientações.
11. REFERÊNCIAS BIBLIOGRÁFICAS
1-Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163(13):1514-22.;
2- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double- blind study. Arch Intern Med. 2002;162(18):2113-23.
3- Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-termeffects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet.2001;357(9252):251-6.;
4- Noack W, Fischer M, Forster KK, Rovati LC, Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994;2(1):51- 9.;
5- Moscoso FV, Maldonado CG. Evaluación clínica de la asociación sulfato de glucosamina-condroitin sulfato, em el tratamiento de la artrosis de cadera y de rodilla. Ver Fac CS Méd (Quito-Ecuador), 2000; 25(1):37-42.;
6- Michel BA, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3):779-86.
7- Vidal y Plana RR, KARZEL K: Glucosamine: its importance for the metabolism of articular cartilage. 2. Studies on articular cartilage. Fortschr Med. 1980 Jun 5;98(21):801-6. German.
8- Reichelt A, Forster KK, & Fischer M: Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee: a randomised, placebo-controlled, double-blind study. Arzneimittelforschung 1994; 44:75-80.
9- Reyes G C, Koda RT, Lien E J: Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey. Progress in Drug Research. 2000; 55:81-103.
10- RTECS: Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2001; provided by Thomson Healthcare Inc., Greenwood Village, CO.
11- S Fabro: The Reproductive Toxicology Center (eds): REPROTOX (electronic version). Georgetown University Medical Center and Reproductive Toxicology Center, Columbia Hospital for Women Medical Center. Washington, DC (Internet Version). Edition expires Feb/28/1999; provided by Thomson Healthcare Inc., Greenwood Village, CO.
12- Tapadinhas MJ, Rivera IC, & Bignamini AA: Oral glucosamine sulphate in the management of arthrosis: report on a multi- centre open investigation in Portugal. Pharmatherapeutica 1982; 3:157-168.
13- Qiu GX, Gao SN, & Giacovelli G: Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis.Arzneim-Forsch/Drug Res 1998; 48:469-474.
14- Barclay TS, Tsourounis C, & McCart GM: Glucosamine. Ann Pharmacother 1998; 32:574-580.
15- Drovanti A, Bignamini AA, & Rovati AL: Therapeutic activity of oral glucosamine sulfate in osteoarthritis: a placebo- controlled double-blind investigation. Clin Ther 1980; 3:260-272.
16- da Camara CC, Dowless GV: Glucosamine sulfate for osteoarthritis. Ann Pharmacother. 1998 May;32(5):602-3.
17- Matheson AJ & Perry CM. Glucosamine. A review of its use in the management of osteoarthritis. Drugs Aging 2000; 20 (14):1041-1060.
18- Setnikar I et al. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43(10):1109-
19- Drugdex Drug Evaluations, Glucosamine; Micromedex, 2007.
Superdosagem condroflex
CONDROFLEX com posologia, indicações, efeitos colaterais, interações e outras informações. Todas as informações contidas na bula de CONDROFLEX têm a intenção de informar e educar, não pretendendo, de forma alguma, substituir as orientações de um profissional médico ou servir como recomendação para qualquer tipo de tratamento. Decisões relacionadas a tratamento de pacientes com CONDROFLEX devem ser tomadas por profissionais autorizados, considerando as características de cada paciente.